The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis
CONCLUSIONS: Among postmenopausal women with osteoporosis, clinical vertebral fractures and new vertebral fractures decreased more in patients receiving teriparatide than in those receiving bisphosphonate. Although there were no differences in adverse events across subgroups, patients receiving teriparatide had a higher rate of dizziness than those receiving bisphosphonate.The results of this work will provide a reference for clinicians to select appropriate anti-osteoporosis drugs by comprehensively considering individual differences such as fracture risk and dizziness tolerance.PMID:38064598 (Source: Alternative Therapie...
Source: Alternative Therapies in Health and Medicine - December 8, 2023 Category: Complementary Medicine Authors: Qi Zhong Yuanyue Liao Wen Zou Source Type: research
Treatment for Gorham-Stout syndrome with a combination of teriparatide and denosumab
This study is the first report to show that teriparatide combined with denosumab can be used to treat Gorham-Stout syndrome. (Source: Osteoporosis International)
Source: Osteoporosis International - December 8, 2023 Category: Orthopaedics Source Type: research
Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis
CONCLUSIONS: Over time, numerous studies have demonstrated the efficacy of bisphosphonates and teriparatide in ameliorating pain. In this study, the efficacy of teriparatide surpassed that of bisphosphonates in certain aspects, such as the initial 6-month union rates and reduction in the progression of segmental kyphosis. However, bisphosphonates and teriparatide yield similar and favorable union rates at 1 year and final follow-up.PMID:38050359 | DOI:10.31616/asj.2023.0109 (Source: Asian Spine Journal)
Source: Asian Spine Journal - December 5, 2023 Category: Orthopaedics Authors: Vishnu Vikraman Nair Vishal Kundnani Abhijith Shetty Manikant Anand Mukul Jain Nikhil Dewnany Source Type: research
